Northern Biologics/Mosaic Biomedicals
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Northern Biologics/Mosaic Biomedicals - overview
Location
Toronto, ON, Canada
Primary Industry
Healthcare Specialists
About
Based in Toronto, Canada, Northern Biologics/Mosaic Biomedicals is a result of the merger between Northern Biologics which develops antibody-based therapeutics for oncology and fibrosis and Mosaic Biomedicals which develops oncology treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s immune system.
Primary Industry
Healthcare Specialists
Sub Industries
Oncology/Cancer Treatment
Total Amount Raised
Subscriber access only
Northern Biologics/Mosaic Biomedicals - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Mosaic Biomedicals SL, Northern Biologics Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.